M&A Deal Summary |
|
|---|---|
| Date | 2021-06-07 |
| Target | Molecular Products |
| Sector | Chemicals |
| Buyer(s) | Filtration Group |
| Sellers(s) | Arlington Capital Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1942 |
| Sector | Manufacturing |
| Revenue | 1.3B USD (2017) |
Filtration Group designs and manufactures filtration systems and components for applications in healthcare, life sciences, environmental safety, and industrial processes. Filtration Group’s portfolio includes air, liquid, and process filtration solutions used across global markets to improve air quality, product purity, and equipment efficiency.. Filtration Group was founded in 1942 and is based in Austin, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 17 |
| Sector: Chemicals M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 12 of 12 |
| Country: United Kingdom M&A | 2 of 2 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-05-26 |
Oxyphen
Wetzikon, Switzerland Oxyphen is a manufacturer of microporous track-etched membranes which are used in the pharmaceutical, biotechnology and transportation industries for drug discovery, cell growth, tissue engineering, drug delivery and sensor technology. Oxyphen was founded in 1969 and is based in Wetzikon, Switzerland. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 7.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Arlington Capital Partners is a middle-market private equity firm focused on buyouts and recapitalizations in targeted growth industries. Arlington targets US based companies valued between $50 and $500 million with strong potential for organic growth and possible consolidation opportunities. Sectors of interest include business services and outsourcing, aerospace/defense, federal and commercial IT, media, education and training, healthcare services, and manufacturing. Arlington Capital was formed in 1999 and is headquartered in Washington DC.
| DEAL STATS | # |
|---|---|
| Overall | 32 of 40 |
| Sector: Chemicals M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 16 of 20 |
| Country: United Kingdom M&A | 2 of 2 |
| Year: 2021 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-12-07 |
Everest Clinical Research
Markham, Ontario, Canada Everest Clinical Research is a contract research organization (“CRO”) providing a comprehensive suite of mission-critical clinical research services to the worldwide pharmaceutical, biotechnology, and medical device industries across Phase I-IV trials. Everest Clinical Research was founded in 2004 and is based in Markham, Ontario. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-12 |
TRP Infrastructure Services
Fort Worth, Texas, United States TRP Infrastructure Services is a provider of thermoplastic striping, painting and markers, rumble strips and traffic control services, including: delineation devices, warning signs and maintenance & consulting services. The majority of the Company’s revenue is derived directly or indirectly from the Texas Department of Transportation and local municipalities. TRP Infrastructure Services was founded in 2010 and is headquartered in Fort Worth, Texas. |
Buy | - |
